Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Haptoglobin Administration in Cardiovascular Surgery
jRCTs051250244Active, not recruiting
- Sponsor
- Eiken Chemical
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of haptoglobin in Conditions requiring cardiac surgery with cardiopulmonary bypass, sponsored by Eiken Chemical. Primary endpoint: Plasma free hemoglobin concentration. Started May 2026; status: active, not recruiting.
02
Drugs
haptoglobin
03
Conditions
Conditions requiring cardiac surgery with cardiopulmonary bypass
Beyond the preview
Go deeper on jRCTs051250244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250244.